Cart
sales@molnova.com
Pratosartan
CAS No. 153804-05-8
Pratosartan( FW 7203 | KD 3-671 | KT 3671 )
Catalog No. M21854 CAS No. 153804-05-8
Pratosartan, which is an orally active angiotensin II (AII) antagonist, exhibiting selective and potent antagonistic activity to AT1 subtype. Pratosartan is a new angiotensin II type 1 receptor blocker.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 873 | In Stock |
|
| 50MG | 1782 | In Stock |
|
| 100MG | 2250 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePratosartan
-
NoteResearch use only, not for human use.
-
Brief DescriptionPratosartan, which is an orally active angiotensin II (AII) antagonist, exhibiting selective and potent antagonistic activity to AT1 subtype. Pratosartan is a new angiotensin II type 1 receptor blocker.
-
DescriptionPratosartan, which is an orally active angiotensin II (AII) antagonist, exhibiting selective and potent antagonistic activity to AT1 subtype. Pratosartan is a new angiotensin II type 1 receptor blocker. Pratosartan is an effective and well tolerated antihypertensive drug, and may has beneficial effect on hypertensive patients with some metabolic disorders.
-
In VitroPratosartan, which is an orally active angiotensin II (AII) antagonist, exhibiting selective and potent antagonistic activity to AT1 subtype. Pratosartan is a new angiotensin II type 1 receptor blocker. Pratosartan is an effective and well tolerated antihypertensive drug, and may has beneficial effect on hypertensive patients with some metabolic disorders.
-
In Vivo——
-
SynonymsFW 7203 | KD 3-671 | KT 3671
-
PathwayGPCR/G Protein
-
TargetAngiotensin Receptor
-
Recptorangiotensin II receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number153804-05-8
-
Formula Weight426.51
-
Molecular FormulaC??H??N?O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1CCCCC2=C1N(CC3=CC=C(C4=CC=CC=C4C5=NN=NN5)C=C3)C(CCC)=N2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Sonegawa M, et al. Synthesis and pharmacological activity of the metabolites of Pratosartan. Chem Pharm Bull (Tokyo). 2006 Jun;54(6):782-7.
2. Ogihara T, et al. Clinical efficacy of a new angiotensin II type 1 receptor blocker, pratosartan, in hypertensive patients. Hypertens Res. 2008 Feb;31(2):281-7.
molnova catalog
related products
-
Azilsartan medoxomil...
An orally administered angiotensin II receptor type 1 antagonist with IC50 of 0.62 nM.
-
Olmesartan medoxomil
An angiotensin II receptor antagonist which has been used for the treatment of high blood pressure.
-
C-Type Natriuretic P...
CNP, a member of the natriuretic peptide family, was first identified in porcine brain and later found in other mammals as well as non-mammals. Processing of the CNP precursor gives rise to CNP-22 and its N-terminally elongated form, CNP-53. The CNPs share considerable sequence homology with ANP and BNP within the disulfide loop and exert similar pharmacological actions, although with different relative potencies.
